DGAP-Adhoc: Settlement of law suits against resolutions of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: Settlement of law suits against resolutions of the annual general meeting 2014 on appropriation of profits and capital reduction/share repurchase 2014

RHÖN-KLINIKUM AG / Key word(s): Share Buyback/AGM/EGM 29.09.2014 20:06 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- In the fast track proceeding (Freigabeverfahren) initiated by the Company in order to effect the registration of the resolution of the annual general meeting 2014 on item 3 of the agenda (capital reduction and share repurchase 2014) with the commercial register, the Company on the one hand and Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG on the other today agreed to a settlement proposal of the Higher Regional Court of Nürnberg. The settlement comprises the amicable ending of the fast track proceeding and the agreement to declare the law suits filed by Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG against the resolutions of the annual general meeting 2014 on item 2 (appropriation of profits) and item 3 (capital reduction and share repurchase 2014) moot (für erledigt erklären). Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG expressly consent to the entry of the resolution on capital reduction into the commercial register. The settlement agreement still requires formal determination by resolution of the Higher Regional Court of Nürnberg. The share repurchase 2014 will be implemented once the resolution on capital reduction has been entered into the commercial register. Once determined, the terms of the share repurchase 2014 will be announced separately. The law suits filed by Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG against the resolution on item 7.4 of the agenda of the annual general meeting 2014 regarding the election of Prof. Dr. h.c. Ludwig Georg Braun as member of the supervisory board remain unaffected by the aforementioned settlement. Contact Dr. Kai G. Klinger SVP - Investor Relations & Corporate Finance RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: +49 (0) 9771 65-1318 Telefax: +49 (0) 9771 99-1736 E-Mail: ir@rhoen-klinikum-ag.com Achim Struchholz Head of Corporate Communications RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: +49 (0) 9771 65-1327 Telefax: +49 (0) 9771 65-1820 E-Mail: kommunikation@rhoen-klinikum-ag.com 29.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 14

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 19

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 18

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 17

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 15

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 10

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 18

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Flying Bikes Market Expansion: A Journey to New Heights

Updated Category News Views 155

Flying Bikes Market Growth Projections The global flying bikes market is currently on an impressive trajectory. Originally valued at US$ 80.6 billion, it is anticipated to reach an astounding US$ 377.5 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 18.7% during this period. Innovative Performance Metrics Driving Demand Performance metrics for...

Continue Reading
Diversified Energy Enhances Portfolio with New Acquisition Deal

Updated Category News Views 205

Acquisition of Natural Gas Properties by Diversified Energy Bolt-on Acquisition Increases Coal Mine Methane Environmental Credit Cash Flow, Expands Midstream Infrastructure, and Enhances Southern Appalachia Prices Strategic Refinance Incorporates 40% Improvement in Cash Flow from New Hedges and an Innovative Master Trust Structure Solidifies Diversified as the Leading...

Continue Reading
MetroCity Bankshares and First IC Corporation Merge for Growth

Updated Category News Views 129

Strategic Merger of MetroCity Bankshares and First IC Corporation MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced an exciting development as it has secured all necessary regulatory approvals for its merger with First IC Corporation (OTCEM: FIEB). This strategic combination aims to enhance their banking services and expand their operational footprint across several...

Continue Reading
Crown's Revenue Surges in First Quarter Financial Update

Updated Category News Views 178

Crown Electrokinetics Corp. Financial Performance Update Crown Electrokinetics Corp. (NASDAQ: CRKN) has recently released its financial results, marking significant developments for the first quarter of 2025. This summary includes insights into revenue growth, operational accomplishments, and strategic advancements that highlight the company’s evolving presence in the...

Continue Reading
Eileen Revamps Retail Dynamics with New Investment Boost

Updated Category News Views 6

Capital Surge Fuels Eileen's Ambitious Expansion Now, here's something that's bound to shake up the retail tech scene. Eileen Inc., a fresh face in retail technology, just grabbed a strategic investment from DisPact Ventures. This isn't just another drop in the bucket; it's throwing serious weight into their operations to gear up for a monstrous scale. The injection into...

Continue Reading